Invesco’s NxStage Medical Inc. NXTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-53,449
Closed -$1.53M 3936
2018
Q4
$1.53M Buy
53,449
+27,702
+108% +$787K ﹤0.01% 2724
2018
Q3
$718K Buy
25,747
+881
+4% +$24.8K ﹤0.01% 3281
2018
Q2
$694K Buy
24,866
+5,339
+27% +$143K ﹤0.01% 3303
2018
Q1
$485K Sell
19,527
-1,704,930
-99% -$41.5M ﹤0.01% 3340
2017
Q4
$41.8M Sell
1,724,457
-676,047
-28% -$17.8M 0.02% 851
2017
Q3
$66.3M Sell
2,400,504
-53,471
-2% -$1.43M 0.02% 646
2017
Q2
$61.5M Sell
2,453,975
-45,355
-2% -$1.12M 0.02% 666
2017
Q1
$67.1M Sell
2,499,330
-19,119
-0.8% -$528K 0.02% 642
2016
Q4
$66M Sell
2,518,449
-8,040
-0.3% -$199K 0.02% 669
2016
Q3
$63.1M Buy
2,526,489
+64,976
+3% +$1.51M 0.02% 663
2016
Q2
$53.4M Buy
2,461,513
+178,121
+8% +$3.18M 0.02% 727
2016
Q1
$34.2M Buy
2,283,392
+100,394
+5% +$1.68M 0.01% 912
2015
Q4
$47.8M Buy
2,182,998
+2,167,767
+14,233% +$40.4M 0.02% 776
2015
Q3
$240K Buy
15,231
+363
+2% +$5.82K ﹤0.01% 3514
2015
Q2
$212K Sell
14,868
-1,741
-10% -$29.5K ﹤0.01% 3707
2015
Q1
$287K Sell
16,609
-71,649
-81% -$1.27M ﹤0.01% 3541
2014
Q4
$1.58M Buy
88,258
+71,272
+420% +$1.15M ﹤0.01% 2665
2014
Q3
$223K Buy
16,986
+761
+5% +$10.2K ﹤0.01% 3619
2014
Q2
$233K Hold
16,225
﹤0.01% 3648
2014
Q1
$207K Buy
16,225
+14,920
+1,143% +$195K ﹤0.01% 3725
2013
Q4
$13K Buy
1,305
+30
+2% +$341 ﹤0.01% 4193
2013
Q3
$17K Hold
1,275
﹤0.01% 4160
2013
Q2
$18K Buy
+1,275
New +$16K ﹤0.01% 4140

Other funds holding NXTM

Invesco's NXTM Position: Q1 2019 in Review

Invesco sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 53,449 shares — an estimated $1.53M sold.

Invesco first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $67.1M in Q1 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Invesco reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Invesco sold 53,449 NxStage Medical Inc. shares in Q1 2019, an estimated $1.53M.
  • Invesco first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
  • Invesco's NxStage Medical Inc. position peaked at $67.1M in Q1 2017.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Invesco's 13F filing for Q1 2019, filed 15 May 2019.